Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Long-awaited HBV therapy launched in Japan

Nov. 21, 2000

Highly effective anti-H. pylori agents designed at Bayer

Nov. 14, 2000

Pharmacodynamics of antisense drug ISIS-22023 correlated with concentrations at site of action

Nov. 14, 2000

Pariet receives E.U. approval for H. pylori eradication in peptic ulcer disease

Nov. 14, 2000

Trimetazidine analogue exerts significant hepatoprotective effects in I/R injury model in rats

Nov. 13, 2000

Novel peptides for HCV infection emerge from R&D at Boehringer Ingelheim

Nov. 10, 2000

Significant reduction in HBV DNA obtained on adefovir dipivoxil in lamivudine-resistant HBV patients

Nov. 10, 2000

Major breakthrough in HBV therapy reported at AASLD

Nov. 10, 2000

Addition of oprelvekin allows completion of full-dose therapy for hepatitis C

Nov. 9, 2000

Enzo Biochem's oral HBV protein product highlighted at AASLD meeting

Nov. 8, 2000

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...